2026 NPPES data Pulmonary Disease Physician NPI 1548209646 M.D.
Verify on CMS →

HSIEN-WEN HSU, M.D.

Pulmonary Disease Physician in PITTSBURG, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
3K
Medicare Part D claims · 422 beneficiaries · Pulmonary Disease Physician avg: 1K
Generic prescribing
45%
generic claims · 55% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$694.37
6 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

HSIEN-WEN HSU, M.D. filed 2,765 Medicare Part D claims in 2023 as a Pulmonary Disease Physician in PITTSBURG, California, prescribing 45% generic.

3K
Part D claims, 2023
45%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

HSIEN-WEN HSU, M.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

2,765 Top 12% higher than 88% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). Below this entry. 1,000–1,200: 31,827 prescribers (2%). Below this entry. 1,200–1,400: 26,224 prescribers (2%). Below this entry. 1,400–1,600: 21,710 prescribers (2%). Below this entry. 1,600–1,800: 19,072 prescribers (1%). Below this entry. 1,800–2,000: 16,451 prescribers (1%). Below this entry. 2,000–2,200: 213,991 prescribers (16%). This entry sits in this band. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board certification likely (heuristic — not verified)

HSIEN-WEN HSU, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about HSIEN-WEN HSU, M.D.?

Quality data not reported

NPI registry status

Active

Issued 06/05/2006

NPI 1548209646

Primary specialty

Pulmonary Disease Physician

Mid-sized

9,271 US NPIs in this specialty

Medicare Part D claims

2,765 90% vs specialty avg

2023 prescription claims

Specialty avg: 1,457

Specialty distribution in California

How Pulmonary Disease Physician compares to other specialties among California providers

California providers

Pulmonary Disease Physician share within California

1. Pulmonary Disease Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Pulmonary Disease Physician share within California

Specialty board-certification context

Estimated specialty board-certified rate — Pulmonary Disease Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Pulmonary Disease Physician ABMS/AOA estimate

Est. board-certified rate (Pulmonary Disease Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Pulmonary Disease Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

HSIEN-WEN HSU, M.D. appears in the CMS NPPES registry as a Pulmonary Disease Physician provider holding M.D. credentials at 2220 GLADSTONE DR, PITTSBURG, CA, 94565, with a listed phone of (925) 432-3318. NPI 1548209646 was issued on 06/05/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what HSU most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 2,765 prescription claims written by this provider, covering 422 Medicare beneficiaries and totaling roughly $1.4 million in drug spend, split 55% brand-name and 45% generic by claim count, with an opioid prescribing rate of 0.7%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Pulmonary Disease Physician is a mid-sized specialty nationwide, with 9,271 enrolled providers across 53 states and an average of 1,457 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

2220 GLADSTONE DR
PITTSBURG, CA 94565

Provider Details

NPI 1548209646
Specialty Pulmonary Disease Physician
Credentials M.D.
Gender Male
NPI Issued 06/05/2006

Hospital and facility affiliations

Facilities where HSIEN-WEN HSU, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

PITTSBURG-ANTIOCH MEDICAL GROUP A PROFESSIONAL CORPORATION
PITTSBURG, CA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for HSIEN-WEN HSU, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$694

Largest payer

AstraZeneca Pharmaceuticals LP

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to HSIEN-WEN HSU, M.D.. To verify HSIEN-WEN HSU, M.D.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Brand-heavy

HSIEN-WEN HSU, M.D. — brand share 55.0%
Specialty average (est.)

55% brand-name claims vs 45% generic, on 2,765 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

2,765
Total Claims
$1.4M
Total Drug Cost
422
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
4,287
Total Day Supply
120,455
Brand vs Generic
55% brand / 45% generic
Brand Drug Cost
$1.3M
Generic Drug Cost
$83K
Opioid Claims
19 (0.7% rate)
Antibiotic Claims
277

Patient Demographics

Average Patient Age
74.3 years
Avg HCC Risk Score
2.18
Gender Split
60% female / 40% male
Age Distribution
<65: 53, 65-74: 139, 75-84: 167, 85+: 63

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What HSIEN-WEN HSU, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Trelegy Ellipta
Fluticasone/Umeclidin/Vilanter
344
Symbicort
Budesonide/Formoterol Fumarate
218
Albuterol Sulfate Hfa
Albuterol Sulfate
216
Azithromycin
176
Breztri Aerosphere
Budesonide/Glycopyr/Formoterol
162
Prednisone
151
Roflumilast
129
Ventolin Hfa
Albuterol Sulfate
95
Breo Ellipta
Fluticasone/Vilanterol
92
Spiriva Respimat
Tiotropium Bromide
87

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Pulmonary Disease Physician Overview

How HSIEN-WEN HSU, M.D. fits within the Pulmonary Disease Physician landscape nationally.

9,271
Pulmonary Disease Physician Providers in US
53
States with Pulmonary Disease Physician
1,457
Avg Claims per Provider

HSIEN-WEN HSU, M.D.'s 2,765 claims are above the specialty average of 1,457.

Nearby Pulmonary Disease Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as HSU.

Compare Pulmonary Disease Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is HSIEN-WEN HSU, M.D.'s specialty?
HSIEN-WEN HSU, M.D. specializes in Pulmonary Disease Physician and practices in PITTSBURG, California. Credentials: M.D..
How much does HSIEN-WEN HSU, M.D. prescribe under Medicare Part D?
In 2023, HSIEN-WEN HSU, M.D. wrote 2,765 Medicare Part D claims totaling $1.4M in drug costs for 422 beneficiaries.
Where is HSIEN-WEN HSU, M.D. located?
HSIEN-WEN HSU, M.D. is located at 2220 GLADSTONE DR, PITTSBURG, CA, 94565. Phone: (925) 432-3318.
What is HSIEN-WEN HSU, M.D.'s NPI number?
HSIEN-WEN HSU, M.D.'s National Provider Identifier (NPI) is 1548209646, issued on 06/05/2006.
Does HSIEN-WEN HSU, M.D. prescribe more brand-name or generic drugs?
HSIEN-WEN HSU, M.D.'s prescribing is 55% brand-name and 45% generic drugs by claim count, with $1.3M in brand drug costs.
Does HSIEN-WEN HSU, M.D. prescribe opioids?
Yes, HSIEN-WEN HSU, M.D. had 19 opioid claims in 2023 with an opioid prescribing rate of 0.7%.
How many Pulmonary Disease Physician providers are there in the US?
There are 9,271 Pulmonary Disease Physician providers across 53 states in the US. The average Pulmonary Disease Physician provider writes 1,457 Medicare Part D claims per year.
What drugs does HSIEN-WEN HSU, M.D. prescribe most often?
Based on 2023 Medicare Part D data, HSIEN-WEN HSU, M.D.'s most frequently prescribed drugs include Trelegy Ellipta, Symbicort, Albuterol Sulfate Hfa. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does HSIEN-WEN HSU, M.D. accept Medicare?
HSIEN-WEN HSU, M.D. appears in CMS Medicare data with 2,765 Part D claims and 422 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify HSIEN-WEN HSU, M.D.'s credentials?
HSIEN-WEN HSU, M.D.'s NPI is 1548209646 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology